Viewing Study NCT04990258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-02-05 @ 11:17 PM
Study NCT ID: NCT04990258
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-24
First Post: 2021-06-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Inflammatory Bowel Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IBD UC View